InvestorsHub Logo
Followers 2543
Posts 250734
Boards Moderated 34
Alias Born 05/06/2014

Re: None

Thursday, 01/29/2015 3:04:35 PM

Thursday, January 29, 2015 3:04:35 PM

Post# of 91832
$PMCB A Refresher- The "Cell In A Box"



This is what all the hoopla is about. You are looking at a "Chemo Therapy Uber Car". This is a delivery system for cancer therapies.

This capsule is owned and manufactured by PMCB, and it's about the size of the head of a pin. Once fabricated, the capsules can be frozen and stored for over 5 years. Each capsule can hold about 10,000 chemo therapy cells.

The capsules are injected directly into or near a tumor, and the capsule will deliver the treatment directly to the cancer cells over a long period of time. In past studies it has been demonstrated less toxic medication is required for a far better outcome for patients- the Holy Grail of cancer therapy is life extension while minimizing side effects. PMCB delivers this as reliably as UBER delivers passengers.

Dr. Von Hoff Factor



Last May PMCB delivered a major breakthrough. Translational Drug Development of Arizona agreed to conduct preclinical and clinical trials.

The gentleman you see pictured here is the head of Translational Drug- Dr. Daniel Von Hoff. His company has spent the last 2 decades developing cancer drugs. He was on President Bush's National Cancer Society Board, the FDA's oncology Advisory Committee, and is the former President of the American Association for Cancer Research.

Under Von Hoff's direction, the first preliminary studies have been concluded, and the clinical protocol for the Phase 2B trial has been developed. The next step is planning the commencement of the trial with the FDA and other similar agencies Internationally.

On December 22 PMCB announced its Pancreatic Cancer Therapy had received "Orphan Drug Status" from the US FDA- a huge coup. Thanks to the proximity to Christmas, the announcement did not receive proper recognition. To see the evidence on the FDA web site, simply Click Here.

Orphan Drug status is reserved for drugs or treatments for "rare, life threatening diseases." Once approved, PMCB will own the drug exclusively for 7 years.

"Patience, persistence and perspiration make an unbeatable combination for success."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.